The impact of highest doses of ACEi/ARB therapy on mortality of patients suffering from heart failure with reduced ejection fraction: a long-term follow-up, propensity-matched cohort study
1 September 2019 (08:30 - 12:30)
Organised by:
Abstract
About the speaker
Gottsegen National Cardiovascular Center, Budapest (Hungary)
8 More presentations in this session
Access the full session
The Event
ESC Congress 2019
1 September 2019
08:30 CET
You may be interested in
Congress Session
